Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Similar to ABVX, NKTR also experienced its own drawdown during the quarter. However, semi-positive highlight...
— Paul Cerro
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Nektar Therapeutics
No other institutional pitches found for this ticker yet.
More institutional theses from Cedar Grove Capital Management
OneSpaWorld ($OSW) is an outsourced, asset-light provider of health, wellness, and spa services operating aboard international cruise ships and destination resorts. The manager re-entered...
Hims & Hers Health ($HIMS) provides direct-to-consumer digital telehealth services, offering subscription consultations and personalized treatments across dermatology, sexual health, mental wellness, and weight loss. The manager is...
Evolv Technologies ($EVLV) provides AI-powered weapons-detection screening gateways for high-traffic environments, including schools, stadiums, and hospitals. Unlike conventional walkthrough...